Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-24 @ 11:50 PM
NCT ID:
NCT06183151
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years old at the time of study entry
* Currently receiving standard of care systemic anti-cancer therapy (chemotherapy, immunotherapy, endocrine and targeted therapy) for solid organ malignancy
* Scheduled to be undergoing routine CBC blood tests as part of standard of care
* Can provide written informed consent
* In the Investigator's opinion, is able and willing to comply with all study requirements
Exclusion Criteria:
* History or current diagnosis of hematological malignancy (including bone and lymph)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06183151
Study Brief:
Protocol Section:
NCT06183151